Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series B round brings $45mm to Harpoon Therapeutics; receives $20mm second tranche

Executive Summary

Oncology start-up Harpoon Therapeutics raised $45mm through its Series B round. Arix Bioscience and New Leaf Ventures co-led, and were joined by additional investor Taiho Ventures and returning backer MPM Capital. Arix and New Leaf have joined Harpoon’s board of directors, and Taiho’s president will be on the board as an observer.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register